Edition:
United States

OvaScience Inc (OVAS.OQ)

OVAS.OQ on NASDAQ Stock Exchange Global Market

0.95USD
18 May 2018
Change (% chg)

$0.01 (+0.56%)
Prev Close
$0.94
Open
$0.93
Day's High
$0.96
Day's Low
$0.93
Volume
13,594
Avg. Vol
75,872
52-wk High
$1.96
52-wk Low
$0.71

Latest Key Developments (Source: Significant Developments)

Ovascience Says ‍Reducing Headcount By Approximately 50 Percent​
Wednesday, 3 Jan 2018 04:06pm EST 

Jan 3 (Reuters) - Ovascience Inc ::OVASCIENCESM ANNOUNCES CORPORATE UPDATE.OVASCIENCE INC - ‍REDUCING HEADCOUNT BY APPROXIMATELY 50 PERCENT​.OVASCIENCE INC - ‍MAJORITY OF REDUCTION IN PERSONNEL IS EXPECTED TO BE COMPLETED BY MARCH 2018​.OVASCIENCE INC - JAMES LILLIE JOINING AS CHIEF SCIENTIFIC OFFICER.OVASCIENCE INC - ‍AS A RESULT OF REDUCTION IN PERSONNEL, CO EXPECTS TO REALIZE ANNUALIZED COST SAVINGS BEGINNING IN Q2 OF 2018​.OVASCIENCE INC - ‍ESTIMATES THAT IT WILL INCUR ONE-TIME COSTS OF APPROXIMATELY $1.0 MILLION TO $1.5 MILLION RELATED TO RESTRUCTURING PLAN​.OVASCIENCE INC - ‍PLANS TO INITIATE A MULTI-CENTER, PROSPECTIVE, CONTROLLED, PHASE 1B/2A CLINICAL TRIAL OF OVAPRIME​.OVASCIENCE INC - ‍EXPECTS TO BEGIN PATIENT ENROLLMENT IN FIRST HALF OF 2018 AND TO REPORT INITIAL CLINICAL DATA IN 2019​ FROM PLANNED OVAPRIME TRIAL.  Full Article

Ovascience reports Q3 loss per share $0.26
Thursday, 2 Nov 2017 04:02pm EDT 

Nov 2 (Reuters) - Ovascience Inc :Ovascience reports third quarter 2017 financial results.Q3 loss per share $0.26.Q3 earnings per share view $-0.40 -- Thomson Reuters I/B/E/S.Ovascience Inc - ‍expects to incur additional cash outlays related to restructurings of between $1.0 million and $1.5 million over 2017 and 2018​.Ovascience Inc - ‍anticipates that it will have sufficient funds without additional financing to support its operations into q1 of 2020​.  Full Article

Ovascience names Christophe Couturier as CFO
Tuesday, 6 Sep 2016 04:05pm EDT 

Ovascience Inc : Christophe Couturier has been named chief financial officer, effective immediately .Christophe couturier succeeds Jeff Young, who is pursuing other opportunities and will be leaving ovascience after a transition period.  Full Article

Ovascience Q2 loss per share $0.62
Thursday, 4 Aug 2016 04:01pm EDT 

Ovascience Inc : Q2 earnings per share view $-0.78 -- Thomson Reuters I/B/E/S . Ovascience reports second quarter 2016 financial results . Q2 loss per share $0.62 .Ovascience reports second quarter 2016 financial results.  Full Article

BRIEF-Ovascience Reports Q1 Loss Per Share Of $0.21

* OVASCIENCE REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE